Dr. Lee Schroeder is currently Assistant Professor at the University of Michigan where he is Director of Point-of-Care Testing and Associate Director of Chemical Pathology. His academic focus is at the interface of clinical informatics and health services research, using decision analytic approaches to model and improve the impact of laboratory medicine. This has included research involving laboratory capacity and quality improvement of sub-Saharan African laboratories, modeling the impact of different testing algorithms on health outcomes, and data mining the electronic medical record to better understand the performance of point-of-care testing.
Lee Schroeder completed his BA in physics at the University of Pennsylvania in 1995, his MD/PhD with an NIH Medical Scientist Training Program scholarship award at the University of California, San Diego in 2011, and his pathology residency at Stanford University in 2014. Lee currently serves as Co-Director of a Blue Cross Blue Shield funded pilot program to improve utilization of genetic testing for hereditary cancer syndromes. He is a member of the chemistry resource committee at the College of American Pathologists. He has received the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Physicians and Scientists, 2013, the AACC Management Sciences and Patient Safety Division’s Management Sciences Abstract Award, 2013. Lee has published 26 peer-reviewed manuscripts.